LBA22 - Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy with either 5FU/LV plus pan or single-agent pan: Translational analyses of the VALENTINO study

Federica Morano ,Andrea Sartore Bianchi ,Roberto Murialdo ,Vincenzo Adamo ,Alberto Zaniboni ,Marco Tampellini ,Gianluca Tomasello ,Chiara Cremolini ,Saverio Cinieri ,Sara Lonardi ,Fausto Petrelli ,Raffaella Longarini ,Maria Di Bartolomeo ,Laura Fanchini ,Lorenza Rimassa ,Matteo Clavarezza ,Salvatore Corallo ,F.G.M De Braud,Marta Schirripa ,Filippo Pietrantonio

doi:10.1093/annonc/mdy424.023

LBA22 - Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy with either 5FU/LV plus pan or single-agent pan: Translational analyses of the VALENTINO study

Federica Morano , Andrea Sartore Bianchi + Show 18 more

Open Access

https://doi.org/10.1093/annonc/mdy424.023

Copy DOI

Journal: Annals of Oncology	Publication Date: Oct 1, 2018
Citations: 1	License type: publisher-specific-oa

Affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori, Ospedale Niguarda Ca' Granda, Ospedale Policlinico San Martino, Azienda Ospedaliera Universitaria Policlinico "G. Martino", Gruppo di Ricerca Geriatrica, Ospedale San Luigi Gonzaga, Istituti Ospitalieri di Cremona, Azienda Ospedaliera Universitaria Pisana, Ospedale A. Perrino, Istituto Oncologico Veneto, Istituti di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Treviglio, Azienda Ospedaliera San Gerardo, Fondazione Ricerca Molinette, Fondazione Humanitas per la Ricerca, Ente Ospedaliero Ospedali Galliera

#Wild-type Metastatic Colorectal Cancer Patients #RAS Wild-type Metastatic Colorectal Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

LBA22 - Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy with either 5FU/LV plus pan or single-agent pan: Translational analyses of the VALENTINO study

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.